全文获取类型
收费全文 | 8078篇 |
免费 | 960篇 |
国内免费 | 3篇 |
专业分类
9041篇 |
出版年
2022年 | 60篇 |
2021年 | 142篇 |
2020年 | 66篇 |
2019年 | 95篇 |
2018年 | 80篇 |
2017年 | 94篇 |
2016年 | 178篇 |
2015年 | 294篇 |
2014年 | 349篇 |
2013年 | 364篇 |
2012年 | 549篇 |
2011年 | 564篇 |
2010年 | 311篇 |
2009年 | 298篇 |
2008年 | 457篇 |
2007年 | 507篇 |
2006年 | 452篇 |
2005年 | 496篇 |
2004年 | 472篇 |
2003年 | 474篇 |
2002年 | 437篇 |
2001年 | 134篇 |
2000年 | 129篇 |
1999年 | 149篇 |
1998年 | 133篇 |
1997年 | 105篇 |
1996年 | 102篇 |
1995年 | 91篇 |
1994年 | 100篇 |
1993年 | 92篇 |
1992年 | 81篇 |
1991年 | 82篇 |
1990年 | 69篇 |
1989年 | 58篇 |
1988年 | 54篇 |
1987年 | 64篇 |
1986年 | 46篇 |
1985年 | 54篇 |
1984年 | 74篇 |
1983年 | 55篇 |
1982年 | 90篇 |
1981年 | 53篇 |
1980年 | 64篇 |
1979年 | 51篇 |
1978年 | 34篇 |
1977年 | 45篇 |
1976年 | 25篇 |
1975年 | 28篇 |
1974年 | 29篇 |
1968年 | 21篇 |
排序方式: 共有9041条查询结果,搜索用时 15 毫秒
61.
62.
Redzic JS Armstrong GS Isern NG Jones DN Kieft JS Eisenmesser EZ 《Journal of molecular biology》2011,411(1):68-82
CD147 is a type I transmembrane protein that is involved in inflammatory diseases, cancer progression, and multiple human pathogens utilize CD147 for efficient infection. CD147 expression is so high in several cancers that it is now used as a prognostic marker. The two primary isoforms of CD147 that are related to cancer progression have been identified, differing in their number of immunoglobulin (Ig)-like domains. These include CD147 Ig1-Ig2, which is ubiquitously expressed in most tissues, and CD147 Ig0-Ig1-Ig2, which is retinal specific and implicated in retinoblastoma. However, little is known in regard to the retinal specific CD147 Ig0 domain despite its potential role in retinoblastoma. We present the first crystal structure of the human CD147 Ig0 domain and show that the CD147 Ig0 domain is a crystallographic dimer with an I-type domain structure, which maintained in solution. Furthermore, we have utilized our structural data together with mutagenesis to probe the biological activity of CD147-containing proteins, both with and without the CD147 Ig0 domain, within several model cell lines. Our findings reveal that the CD147 Ig0 domain is a potent stimulator of interleukin-6 and suggest that the CD147 Ig0 domain has its own receptor distinct from that of the other CD147 Ig-like domains, CD147 Ig1-Ig2. Finally, we show that the CD147 Ig0 dimer is the functional unit required for activity and can be disrupted by a single point mutation. 相似文献
63.
The inhibition of protein tyrosine phosphatases by pervanadate, a potent activator of B- and T-cells through the induction of tyrosine phosphorylation and downstream signaling events in different activation cascades, efficiently induced apoptosis in lymphoid cell lines. Pervanadate-elicited apoptosis could be blocked by the tyrosine kinase inhibitor herbimycin A. This apoptotic process involved the activation of caspases 3, 8 and 9, the induction of mitochondrial permeability transition, the release of cytochrome C and the fragmentation of chromosomal DNA. T-cells lacking the CD95 receptor or caspase-8 and T-cells stably overexpressing a transdominant negative form of the adaptor protein FADD were still susceptible to pervanadate-induced apoptosis, excluding the involvement of the CD95 system or other FADD-dependent death receptors. The apoptotic program initiated by the inhibition of tyrosine phosphatases did not require the presence of the tyrosine kinase p56lck or phosphatase CD45, whereas Bcl-2 overexpression protected T-cells from pervanadate-induced cytochrome C release, caspase-8 cleavage and apoptosis. 相似文献
64.
Global dysfunction of CD4 T-lymphocyte cytokine expression in simian-human immunodeficiency virus/SIV-infected monkeys is prevented by vaccination 下载免费PDF全文
McKay PF Barouch DH Schmitz JE Veazey RS Gorgone DA Lifton MA Williams KC Letvin NL 《Journal of virology》2003,77(8):4695-4702
Human immunodeficiency virus type 1 infection results in a dysfunction of CD4(+) T lymphocytes. The intracellular events contributing to that CD4(+) T-lymphocyte dysfunction remain incompletely elucidated, and it is unclear whether aspects of that dysfunction can be prevented. The present studies were pursued in a rhesus monkey model of AIDS to explore these issues. Loss of the capacity of peripheral blood CD4(+) T lymphocytes to express cytokines was first detected in simian immunodeficiency virus-infected monkeys during the peak of viral replication during primary infection and persisted thereafter. Moreover, infected monkeys with progressive disease had peripheral blood CD4(+) T lymphocytes that expressed significantly less cytokine than infected monkeys that had undetectable viral loads and intact CD4(+) T-lymphocyte counts. Importantly, CD4(+) T lymphocytes from vaccinated monkeys that effectively controlled the replication of a highly pathogenic immunodeficiency virus isolate following a challenge had a preserved functional capacity. These observations suggest that an intact cytokine expression capacity of CD4(+) T lymphocytes is associated with stable clinical status and that effective vaccines can mitigate against CD4(+) T-lymphocyte dysfunction following an AIDS virus infection. 相似文献
65.
66.
67.
Prudom SL Broz CA Schultz-Darken N Ferris CT Snowdon C Ziegler TE 《Biology letters》2008,4(6):603-605
Common marmoset (Callithrix jacchus) males are bi-parental non-human primates that show extensive paternal behaviour. Fathers are in direct sensory contact with their infants during the natal period. We found that fathers exposed to isolated scents of their infant displayed a significant drop in serum testosterone levels within 20min after exposure, whereas parentally naive males did not. These data suggest that infant's scent may have a causal role in regulating paternal testosterone in their fathers. This is the first study to demonstrate that olfactory cues have an acute effect on paternal care. 相似文献
68.
David R. Bauman Alan Whitehead Lisa C. Contino Jisong Cui Margarita Garcia-Calvo Xin Gu Nancy Kevin Xiuying Ma Lee-yuh Pai Kashmira Shah Xiaolan Shen Sloan Stribling Hratch J. Zokian Joe Metzger Diane E. Shevell Sherman T. Waddell 《Bioorganic & medicinal chemistry letters》2013,23(12):3650-3653
In an effort to understand the origin of blood-pressure lowering effects observed in recent clinical trials with 11β-HSD1 inhibitors, we examined a set of 11β-HSD1 inhibitors in a series of relevant in vitro and in vivo assays. Select 11β-HSD1 inhibitors reduced blood pressure in our preclinical models but most or all of the blood pressure lowering may be mediated by a 11β-HSD1 independent pathway. 相似文献
69.
70.